Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lupromax Pelumas Indonesia Tbk. (LMAX) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Lupromax Pelumas Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Lupromax Pelumas Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lupromax Pelumas Indonesia Tbk. trades at Rp109 (market cap 72.8B, 538K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.3× Lupromax Pelumas Indonesia Tbk.'s market cap, and Lupromax Pelumas Indonesia Tbk. is more actively traded (538K versus 187.4K). Which is the better fit depends on your goals.

LMAXOBAT
Market Cap
72.8B164.65B
Volume
538K187.4K
Lot
5.38K1.87K
Turnover
59.18M44.35M
Average Price
110.01236.67
Value
59.18M44.35M
Indicative Equilibrium Price
242
Indicative Equilibrium Volume
500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LMAX
View details
OBAT
View details

About Lupromax Pelumas Indonesia Tbk.

PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.

Read more on LMAX

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT